IGF1 and metabolic dysfunction-associated steatohepatitis: In the study of NASH model choline-methionine fed db/db mice, IGF-I administration drastically ameliorated histological changes, along with mice in a DMN-induced cirrhotic model, as well as leading to a biochemical improvement [79].